Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Melanoma Research Foundation Welcomes Katie Couric to the 18th Annual NYC Gala

In an unforgettable evening to honor the patients, survivors and caregivers in the melanoma community, Katie will share her personal experiences with cancer and join New York's most generous business and community leaders in support of the one million Americans currently living with melanoma.


News provided by

Melanoma Research Foundation

Sep 19, 2019, 14:00 ET

Share this article

Share toX

Share this article

Share toX


NEW YORK, Sept. 19, 2019 /PRNewswire-PRWeb/ -- The Melanoma Research Foundation (MRF) will host the 18th Annual NYC Gala on Thursday, October 17 at Cipriani Broadway. The gala will welcome award-winning journalist, producer, New York Times best-selling author, podcast host, documentary filmmaker, co-founder of Stand Up to Cancer (SU2C) and longtime cancer prevention advocate, Katie Couric. As part of an unforgettable evening to celebrate and support patients, survivors and caregivers in the melanoma community, Katie will share her personal experiences with cancer and will discuss her latest collaboration with Merck's "With Love, Me" campaign.

In partnership with more than a dozen patient advocacy groups, "With Love, Me" showcases a series of heartfelt letters written by caregivers and cancer survivors to their former selves reflecting upon what they wish they had known – or needed to hear – when they were first coping with a cancer diagnosis. Katie will also be joined by one of the campaign's patient advocates and an active member of the MRF community, melanoma survivor Patrick Guddal.

As a longtime advocate and someone with such a personal connection to the cancer community, Katie’s compassion and tireless support has touched countless lives and brought much needed awareness while giving families across the world a new reason for hope.

Post this

"We are honored to welcome Katie Couric for this incredible event," said Kyleigh LiPira, MRF CEO. "As a longtime advocate and someone with such a personal connection to the cancer community, Katie's compassion and tireless support has touched countless lives and brought much needed awareness while giving families across the world a new reason for hope."

At the 2019 NYC Gala, the MRF will present a Humanitarian Award to Jeffrey Weber, MD, PhD in recognition of the dedication he has shown in his work to advance the field of melanoma research and treatment development. Alexander N. Shoushtari, MD will receive the CURE OM Vision of Hope Award in honor of his exemplary patient care and work towards much needed breakthroughs in ocular melanoma research. For the inspiring bravery they have shown in facing melanoma, Mark McAndrew Brown, Laraine Pirie and Henry Seger will be honored with Courage Awards. A posthumous Courage Award will celebrate the life and enduring memory of Daryl Lynn Pace, whose courageous fight with ocular melanoma was and is an inspiration to our community.

Gala attendees will enjoy a seated gourmet meal, handcrafted cocktails, once-in-a-lifetime auction items and experiences and a special performance by Rebecca Cherry, a critically acclaimed violinist, composer and melanoma survivor. Most importantly, guests will create a powerful and lasting impact by raising life-saving funds for melanoma research. In 2018, gala attendees raised over $1 million to support melanoma research, education and advocacy!

Tickets for the NYC Gala are currently available but will sell out quickly. Sponsorships, journal recognition and VIP packages are also available. Visit https://one.bidpal.net/2019mrfnewyork to purchase tickets, or email [email protected] for more information. Don't miss out on the largest and most anticipated event of the year as New York's most generous business and community leaders come together for an unforgettable night in support of the one million Americans currently living with melanoma – purchase your tickets before they are gone!

About Melanoma
Melanoma is one of the fastest growing cancers in the United States and can strike men and women of all ages, races and skin types. With a 1 in 50 lifetime risk of developing melanoma, this year more than 192,000 Americans will be diagnosed. Melanoma is the leading cause of cancer death in women 25-to 29-years-old and the second most commonly diagnosed cancer in adolescents and young adults 15-to 29-years-old. Most melanomas occur on the skin; but melanoma can also occur in the eye (ocular, or uveal melanoma), in mucous membranes (mucosal melanoma), or even beneath fingernails or toenails.

About the Melanoma Research Foundation
The Melanoma Research Foundation (MRF) is the largest independent organization devoted to melanoma. Since 1998, the MRF has funded over $17 million in melanoma research, transforming the landscape of treatment development. Committed to the support of medical research in finding effective treatments and eventually a cure for melanoma, the MRF also educates patients and physicians about prevention, diagnosis and the treatment of melanoma. The MRF is a committed advocate for the melanoma community, helping to raise awareness of the disease and the need for a cure. The MRF's website is the premier source for melanoma information seekers. More information is available at http://www.melanoma.org. Find the MRF on Facebook and Twitter.

About "With Love, Me"
"With Love, Me," is a new campaign presented by Merck's Your Cancer Game Plan that features a series of heartfelt letters written by caregivers and cancer survivors to their newly diagnosed selves and other caregivers, reflecting upon what they wish they had known when they were diagnosed or providing care. A gallery of patient and caregiver letters is featured on the campaign's website where people can read, view and share stories from others who may have walked in their shoes. Users are also encouraged to share their own #WithLoveMe message online. To learn more, visit WithLoveMe.com.

SOURCE Melanoma Research Foundation

Related Links

http://www.melanoma.org

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.